1 unchanged sentence
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
+Added: Agreement and Plan of Merger, dated as of March, 23, 2022, by and among Avista Public Acquisition Corp.
+Added: II, Ligand Pharmaceuticals Incorporated, OmniAb, Inc.
+Added: and Orwell Merger Sub Inc.
+Added: (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 24, 2022).
+Added: Separation and Distribution Agreement, dated as of March 23, 2022, by and among Avista Public Acquisition Corp.
+Added: II, Ligand Pharmaceuticals Incorporated and OmniAb, Inc.
+Added: (incorporated by reference to Exhibit 2.2 of the Company’s Current Report on Form 8-K filed with the SEC on March 24, 2022).
+Added: Promissory Note, dated as of March 14, 2022, issued by the Company to the Sponsor (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 14, 2022).
+Added: Sponsor Insider Agreement, dated March 23, 2022, by and among OmniAb, Inc., Avista Public Acquisition Corp.
+Added: II and the other parties signatory thereto (incorporated by reference to Exhibit 2.3 of the Company’s Current Report on Form 8-K filed with the SEC on March 24, 2022).
+Added: Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among Avista Public Acquisition Corp.
+Added: II, Avista Acquisition LP II and OmniAb, Inc.
+Added: (incorporated by reference to Exhibit 2.4 of the Company’s Current Report on Form 8-K filed with the SEC on March 24, 2022).
+Added: Employee Matters Agreement, dated as of March 23, 2022, by and among Ligand Pharmaceuticals Incorporated, Avista Public Acquisition Corp.
+Added: II, OmniAb, Inc.
+Added: and Orwell Merger Sub Inc.
+Added: (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 24, 2022).
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Inline XBRL Instance Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Labels Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
+Added: XBRL Instance Document
+Added: XBRL Taxonomy Extension Calculation Linkbase Document
+Added: XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Definition Linkbase Document
+Added: XBRL Taxonomy Extension Labels Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase Document
Filed herewith.
+Added: Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K.
+Added: The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Avista Public Acquisition Corp.
−Removed: November 10, 2021
/s/ David Burgstahler
2 unchanged sentences
Avista Public Acquisition Corp.
−Removed: November 10, 2021
/s/ John Cafasso
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.